dsip nmol conversion Power (in percentage) for 20 nmol/L equivalent dose at u = 2 for a DDP LML CP3 Conversion Kit
Description
A: It is the first triple agonist (GLP-1 + GIP + Glucagon) studied in Phase 3 trials

E., & Eichner, D
The compound in solution is sensitive to oxidation, pH, and temperature

Sierra Club

Karasov WH
